|
Peplin, Incorporation - Company Profile Snapshot
| Company Profile: |
Peplin, Incorporation |
| Ticker: |
PLI |
| Exchanges: |
SYD |
| 2009 Sales: |
n/a |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
AUSTRALIA |
| Employees: |
7 |
Business Description
Peplin, Incorporation. The Group's principal activities are developing and commercializing medical dermatology products for the treatment of cancers and other diseases . Its products include PEP005 Topical gel, which is used for treating Actinic keratosis (AK) and Basal cell carcinoma (BCC), PEP005 IV for Leukemia, PEP005 IC for Superficial bladder cancer and EPUFAs for general cancer and pain. It operates in Australia.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
